Marizomib

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Logo pink
Are you a
new drug developer?
Contact us to learn more about our customized products and solutions.
Name
Marizomib
Accession Number
DB11762
Type
Small Molecule
Groups
Investigational
Description

Marizomib has been used in trials studying the treatment of Cancer, Melanoma, Lymphoma, Glioblastoma, and Malignant Glioma, among others.

Structure
Thumb
Synonyms
  • marizomib
External IDs
Npi 0052 / NPI-0052
Categories
Not Available
UNII
703P9YDP7F
CAS number
437742-34-2
Weight
Average: 313.78
Monoisotopic: 313.1080858
Chemical Formula
C15H20ClNO4
InChI Key
NGWSFRIPKNWYAO-SHTIJGAHSA-N
InChI
InChI=1S/C15H20ClNO4/c1-14-10(7-8-16)12(19)17-15(14,13(20)21-14)11(18)9-5-3-2-4-6-9/h3,5,9-11,18H,2,4,6-8H2,1H3,(H,17,19)/t9-,10+,11+,14+,15+/m1/s1
IUPAC Name
(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl](hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione
SMILES
C[C@@]12OC(=O)[C@@]1(NC(=O)[C@@H]2CCCl)[C@@H](O)[C@H]1CCCC=C1

Pharmacology

Indication
Not Available
Pharmacodynamics
Not Available
Mechanism of action
Not Available
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
Not Available
Food Interactions
Not Available

References

General References
Not Available
External Links
PubChem Compound
11347535
PubChem Substance
347828116
ChemSpider
9522473
BindingDB
50398608
ChEBI
48045
ChEMBL
CHEMBL371405
Wikipedia
Salinosporamide_A

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1Active Not RecruitingTreatmentGlioblastomas / Malignant Gliomas1
1CompletedOtherLung Cancer Non-Small Cell Cancer (NSCLC) / Malignant Lymphomas / Malignant Neoplasm of Pancreas / Melanoma / Multiple Myeloma (MM)1
1CompletedTreatmentAdvanced Malignancies / Cancer, Advanced1
1CompletedTreatmentMalignancies / Malignant Lymphomas1
1CompletedTreatmentMultiple Myeloma (MM) / Multiple Myeloma in Relapse / Refractory Multiple Myeloma1
1, 2RecruitingTreatmentGlioblastomas / Malignant Gliomas1
2CompletedTreatmentMultiple Myeloma (MM)1
2RecruitingTreatmentAnaplastic Ependymoma / Ependymomas1
3RecruitingTreatmentNewly Diagnosed Glioblastoma1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility1.29 mg/mLALOGPS
logP1.39ALOGPS
logP1.24ChemAxon
logS-2.4ALOGPS
pKa (Strongest Acidic)10.32ChemAxon
pKa (Strongest Basic)-2.2ChemAxon
Physiological Charge0ChemAxon
Hydrogen Acceptor Count3ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area75.63 Å2ChemAxon
Rotatable Bond Count4ChemAxon
Refractivity77.39 m3·mol-1ChemAxon
Polarizability31.62 Å3ChemAxon
Number of Rings3ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available

Taxonomy

Description
This compound belongs to the class of organic compounds known as alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof.
Kingdom
Organic compounds
Super Class
Organic acids and derivatives
Class
Carboxylic acids and derivatives
Sub Class
Amino acids, peptides, and analogues
Direct Parent
Alpha amino acids and derivatives
Alternative Parents
Oxoprolines / 1,4-oxazepines / Pyrrolidine-2-ones / Beta propiolactones / Secondary carboxylic acid amides / Secondary alcohols / Oxetanes / Carboxylic acid esters / Lactams / Oxacyclic compounds
show 9 more
Substituents
Alpha-amino acid or derivatives / Oxoproline / Para-oxazepine / 2-pyrrolidone / Pyrrolidone / Beta_propiolactone / Pyrrolidine / Carboxamide group / Carboxylic acid ester / Lactam
show 22 more
Molecular Framework
Aliphatic heteropolycyclic compounds
External Descriptors
organochlorine compound, organic heterobicyclic compound, beta-lactone, gamma-lactam, salinosporamide (CHEBI:48045)

Drug created on October 20, 2016 14:46 / Updated on June 04, 2019 07:26